AIBODY
PrivateLast Round
Seed
Mar 18, 2021
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AIBODY operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in March 2021.
AIBODY is a healthcare technology company that provides a cloud-based digital physiology platform for medical education, clinical training, and research through high-fidelity human body simulations.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Synthetic Data, Drug Discovery
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AIBODY Comparables
Compare AIBODY with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HC Simulation, LLC | 82% | |
| Mantis Biotechnology | 78% | |
| Computational Life | 78% |
For institutional investors. Book with your work email.
AIBODY Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AIBODY Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Raw Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 41% MoM, reaching 2.6K.
- Jun 1, 2025
Monthly visitors increased 53% MoM, reaching 2.9K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 27, 2026
AIBODY launches the jointly accredited 12-module online series The Critical World of Burn Injuries: Best Practices for Emergent Resuscitation in South Carolina on Oct 27th '26, offering AI-powered clinical scenarios and up to 6.75 continuing education credits.
- launchesOct 27, 2026
AIBODY releases The Critical World of Burn Injuries: Best Practices for Emergent Resuscitation, a 12-module online continuing education series for clinicians who triage, assess, and resuscitate burn patients, in South Carolina on Oct 27th '26.
For institutional investors. Book with your work email.
AIBODY Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AIBODY's valuation, stock price, and market status.
Is AIBODY a public or private company?
AIBODY is a private company.
What is the current stock price of AIBODY?
AIBODY is a private company, so its shares have no public market price. Caplight tracks AIBODY's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AIBODY worth (valuation)?
Valuation information for AIBODY is not publicly available.
Can I buy AIBODY stock?
AIBODY shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AIBODY's last funding round?
AIBODY's most recent funding round was Seed on March 18, 2021.
Who are the main investors in AIBODY?
Key investors in AIBODY include Raw Ventures.
Will AIBODY IPO soon?
No public IPO plans have been announced for AIBODY.
How can I track AIBODY secondary market activity?
Caplight tracks bids, offers, and trades in AIBODY's shares on secondary markets.